Choriocarcinoma is the most aggressive and rarest pure form of testicular germ cell tumors, comprising <1% of all testicular GCTs. However, it is more commonly seen as a component of mixed germ cell tumors. It shows extra-embryonal trophoblastic differentiation and is characterized by very high beta-HCG production. On ultrasonography, it appears as a heterogeneous mass with prominent hemorrhagic areas. It shows early and widespread hematogenous metastasis (especially lung and brain). A small primary tumor may present with large metastatic disease. It is sensitive to chemotherapy but prognosis is worse than other GCTs.
Age Range
20-35
Peak Age
28
Gender
Male predominant
Prevalence
Rare
Choriocarcinoma is a high-grade malignant germ cell tumor showing extra-embryonal trophoblastic differentiation. The tumor consists of syncytiotrophoblast and cytotrophoblast cells — this architecture mimics gestational trophoblast. Syncytiotrophoblastic cells produce very high amounts of beta-HCG, and this hormonal activity may lead to paraneoplastic syndromes such as gynecomastia and hyperthyroidism (TSH receptor cross-reactivity). The tumor's prominent hemorrhagic character results from trophoblastic cells' ability to invade maternal vessel walls — the tumor invades vessels, creating widespread intratumoral hemorrhage and necrosis. The heterogeneous, hemorrhagic appearance on ultrasonography is a direct reflection of this intense vascular invasion and hemorrhage tendency. Early hematogenous metastasis results from the tumor's vascular invasion tendency, and widespread pulmonary and brain metastases may develop even when the primary tumor is very small.
The triad of an intratesticular mass with prominent hemorrhagic areas on ultrasonography, very high serum beta-HCG level, and early hematogenous metastasis (especially lung) is pathognomonic for choriocarcinoma. The primary tumor may be small and hidden beneath hemorrhagic changes.
Choriocarcinoma appears as a heterogeneous mass with prominent hemorrhagic areas on ultrasonography. Hemorrhage may be at different stages — acute hemorrhage appears hyperechogenic, subacute hemorrhage hypoechoic-mixed, and old hemorrhage as anechoic-hypoechoic fluid collection. The tumor generally has irregular margins. Primary tumor size may be small (<2 cm) and hemorrhagic changes may mask the tumor. The combination of hemorrhagic testicular mass + very high beta-HCG is highly typical for choriocarcinoma.
Report Sentence
A heterogeneous mass with prominent hemorrhagic areas is seen in the testicular parenchyma; choriocarcinoma should be considered in the clinical context; serum beta-HCG level should be urgently checked.
Color Doppler demonstrates chaotic vascular pattern in choriocarcinoma. Due to the tumor's vascular invasion tendency, perilesional and intralesional irregular vascular structures are seen. Avascular zones in hemorrhagic and necrotic areas coexist with dense vascularity in viable tumoral areas. High flow velocities and low resistive index may be seen. Perilesional hypervascularity reflects the tumor's aggressive vascular invasion.
Report Sentence
Color Doppler examination demonstrates chaotic vascular pattern with irregular vascularity in and around the mass.
On T1-weighted MRI, choriocarcinoma shows prominent T1 hyperintense foci — these areas are consistent with subacute hemorrhage (methemoglobin). Hemorrhage is the most dominant feature of choriocarcinoma, and T1 imaging best demonstrates these hemorrhagic areas. On fat-suppressed sequences, T1 hyperintense areas do not lose signal (distinguishing from fat). On contrast-enhanced series, it may be difficult to distinguish viable tumor areas from hemorrhage.
Report Sentence
Prominent hyperintense foci are seen within the testicular mass on T1-weighted sequences consistent with hemorrhage; choriocarcinoma should be considered in the presence of elevated beta-HCG.
On T2-weighted sequences, choriocarcinoma demonstrates heterogeneous signal. Different stages of hemoglobin degradation products give different T2 signals — deoxyhemoglobin and intracellular methemoglobin appear T2 hypointense, extracellular methemoglobin T2 hyperintense, and hemosiderin markedly T2 hypointense. Viable tumoral areas show low-to-intermediate T2 signal. This complex signal pattern reflects the hemorrhagic character of choriocarcinoma.
Report Sentence
The mass demonstrates heterogeneous signal on T2-weighted sequences with signal changes corresponding to different stages of hemoglobin degradation products.
Diffusion restriction is seen in viable tumoral areas of choriocarcinoma on DWI. However, DWI interpretation may be difficult due to widespread hemorrhage — T1 bright hemorrhagic areas may show false-positive restriction (T1 shine-through) on DWI. Correlation with ADC map is required — ADC is low in true restriction, normal in T1 shine-through. DWI is complementary to contrast-enhanced MRI in detecting viable tumor areas.
Report Sentence
Focal diffusion restriction is seen in the mass on DWI; distinction from hemorrhage-related T1 shine-through artifact should be evaluated with ADC map correlation.
On CT, choriocarcinoma appears as a heterogeneous, hemorrhagic mass. CT plays a critical role primarily in evaluating metastatic disease. Pulmonary metastases are frequently seen as hemorrhagic nodules — solid nodules surrounded by ground-glass halo are associated with pulmonary hemorrhage. Brain metastases may be hemorrhagic and should be evaluated with contrast-enhanced CT/MRI. Retroperitoneal lymphadenopathy may also be detected, but hematogenous spread is more dominant than lymphatic spread in choriocarcinoma.
Report Sentence
Hemorrhagic testicular mass is seen on CT; comprehensive staging for pulmonary and brain metastases is recommended.
Criteria
Very rare (<1%). Entirely trophoblastic differentiation (syncytiotrophoblast + cytotrophoblast). Beta-HCG very high (>100,000 IU/L). AFP normal. Worst prognosis among germ cell tumor types.
Distinct Features
Prominent hemorrhagic mass on ultrasonography, viable tumor tissue may be small. Inverse relationship between tumor size and metastatic rate — small primary tumor, large metastatic disease. T1 hyperintense hemorrhage is the dominant finding on MRI.
Criteria
More commonly seen form. Found together with embryonal carcinoma, teratoma, or other GCT components. Beta-HCG elevated, AFP may be elevated depending on other components. Prognosis worsens as choriocarcinoma percentage increases.
Distinct Features
On ultrasonography, hemorrhagic areas within the heterogeneous mass are seen together with findings of other components. Choriocarcinoma component may be evident as hemorrhagic foci. On MRI, T1 hyperintense hemorrhage + signal characteristics of other components coexist.
Criteria
Primary testicular tumor has undergone spontaneous regression but metastatic disease persists. Small scar/calcification found in testis. Presents with metastatic disease (lung, brain). Beta-HCG elevated, testicular mass very small or absent.
Distinct Features
On ultrasonography, small hyperechogenic scar or calcification, focal hypoechoic area, or normal findings may be seen in the testis. Residual hemorrhagic focus may remain. Disproportionately small primary lesion relative to metastatic disease should be a clue.
Distinguishing Feature
Embryonal carcinoma appears as a heterogeneous solid mass with possible hemorrhagic foci but not as dominant as in choriocarcinoma. Beta-HCG is very high in choriocarcinoma (>100,000 IU/L), moderately elevated in embryonal carcinoma. AFP may be mildly elevated in embryonal carcinoma, normal in pure choriocarcinoma.
Distinguishing Feature
Testicular torsion presents with acute scrotal pain with decreased or absent testicular perfusion on Doppler. Choriocarcinoma usually presents as a painless mass (acute pain from hemorrhage is rare). Beta-HCG elevation distinguishes choriocarcinoma from torsion. Torsion may show whirlpool sign of the spermatic cord.
Distinguishing Feature
Seminoma appears as a homogeneous hypoechoic mass, hemorrhage is rare. Choriocarcinoma appears as a hemorrhagic heterogeneous mass. In seminoma beta-HCG may be mildly elevated (<200 IU/L), in choriocarcinoma very high (>10,000 IU/L). Seminoma is more common at age 30-40, choriocarcinoma at 20-30.
Distinguishing Feature
Mixed NSGCT appears as a heterogeneous mass and may contain choriocarcinoma component. Pure choriocarcinoma is hemorrhage-dominant while mixed tumors also show findings of other components. AFP elevation is expected in mixed tumors, normal in pure choriocarcinoma.
Urgency
emergentManagement
Radical inguinal orchiectomy + urgent BEP chemotherapy. Brain MRI mandatory for staging (high risk of hemorrhagic brain metastasis). IGCCCG poor-prognosis group if beta-HCG >50,000 IU/L or brain/liver/bone metastasis. May require immediate chemotherapy before orchiectomy in life-threatening metastatic disease.Biopsy
Not NeededFollow-up
Beta-HCG monitoring critical — half-life 24-36 hours used for treatment response. CT chest/abdomen/pelvis and brain MRI for staging and response assessment. Long-term surveillance for late relapse.Choriocarcinoma is the most aggressive germ cell tumor requiring urgent treatment. Very high beta-HCG and hemorrhagic metastases may be life-threatening. Brain MRI is mandatory for staging — hemorrhagic brain metastases may require emergency neurosurgery. Urgent chemotherapy may be initiated before orchiectomy in life-threatening metastatic disease. Falls in IGCCCG poor prognosis group (>50%). Beta-HCG half-life (24-36 hours) is critical for monitoring treatment response.
Choriocarcinoma is the most aggressive form of testicular tumors and presents with early hematogenous metastasis. The primary testicular lesion may be very small or completely regressed (burned-out tumor). Metastatic disease is common at diagnosis — lung, brain, and liver are the most common metastatic sites. Treatment is with cisplatin-based chemotherapy (BEP), but prognosis in the pure form is worse than other GCTs. Beta-hCG monitoring is vital for treatment response and recurrence follow-up.